Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000555894 | SCV000636959 | benign | Dilated cardiomyopathy 1AA; Primary familial hypertrophic cardiomyopathy | 2024-01-18 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001722471 | SCV000722098 | likely benign | not provided | 2019-01-22 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000610343 | SCV001442558 | benign | not specified | 2020-10-19 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002431586 | SCV002740594 | likely benign | Cardiovascular phenotype | 2018-12-29 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |